What Causes Elevated LDL Cholesterol Levels?

Elevated LDL cholesterol stems from a long list of causes that range from the genes you inherited to the food on your plate to medications in your cabinet. There is no single switch that flips LDL upward; instead, any factor that increases the liver’s production of LDL particles, slows the clearance of those particles from the bloodstream, or both can push your numbers higher. What makes the topic worth understanding in detail is that many of these causes overlap, and some of the most powerful ones are the least obvious.

Genetics and Familial Hypercholesterolemia

The most dramatic genetic cause of high LDL is familial hypercholesterolemia, or FH. In FH, a mutation in one of a handful of genes cripples the body’s ability to pull LDL particles out of the blood. The most common culprit is a mutation in the gene encoding the LDL receptor itself, but mutations in the gene for apolipoprotein B (the protein on the surface of LDL that docks with the receptor) and in the PCSK9 gene can produce the same result.¹ PCSK9 gain-of-function mutations, for example, cause the receptor to be broken down faster than normal, leaving fewer receptors available to clear LDL.² People who inherit one copy of a faulty gene (heterozygous FH) typically have LDL levels roughly double the normal range from childhood onward. Those who inherit two copies, or certain combinations of mutations in different genes, fare even worse; research has shown that a combined LDL-receptor and LDL-receptor adaptor-protein-1 mutation can produce a more severe phenotype than a homozygous LDL-receptor mutation alone.³

FH gets the most attention because it is extreme, but genetics influences LDL in a subtler way for millions more people. Hundreds of thousands of common gene variants each nudge LDL up or down by a tiny amount. Individually they are trivial, but their aggregate effect can be substantial. A polygenic risk score built from roughly 400,000 of these variants explained about 14% of the total variation in LDL cholesterol in one large study; people in the top 1% of that score had an average LDL nearly 90 mg/dL higher than those in the bottom 1%.⁴ In people who clinically look like they have FH but carry no single large-effect mutation, this kind of polygenic burden is increasingly recognized as the explanation.⁵

Dietary Fats and Their Distinct Effects

Not all dietary fats affect LDL the same way. Long-chain saturated fatty acids, the kind concentrated in butter, red meat, and full-fat dairy, suppress the liver’s production of LDL receptors. With fewer receptors available to pull LDL from the bloodstream, levels rise. Unsaturated fatty acids tend to do the opposite, promoting receptor activity and lowering LDL.⁶ The effect hinges on how each fatty acid shifts cholesterol within liver cells between a regulatory pool and a storage pool, mediated by an internal enzyme that esterifies cholesterol for storage.

Trans fats deserve special mention because they hit LDL through an additional mechanism. The trans isomer of oleic acid (elaidic acid, once abundant in partially hydrogenated oils) not only raises LDL but also lowers HDL cholesterol. One reason is that trans fats boost the activity of cholesteryl ester transfer protein (CETP), a molecule that shuttles cholesterol from HDL particles to LDL particles. In a controlled feeding study, CETP activity rose significantly on a diet enriched with elaidic acid compared with one enriched with its cis counterpart, oleic acid, and the increase correlated with the rise in trans fatty acids in the blood independently of changes in LDL itself.⁷ Lab studies confirmed that trans and cis fatty acids have opposite effects on the CETP-mediated transfer of cholesterol between HDL and LDL, with the trans form increasing transfer and the cis form inhibiting it.⁸ Although regulatory bans have largely eliminated artificial trans fats from the food supply in many countries, they still appear in some processed foods and are worth watching for.

Low-Carb and Ketogenic Diets

One of the more counterintuitive causes of elevated LDL is a very-low-carbohydrate or ketogenic diet, particularly in lean, metabolically healthy people. Researchers have identified a pattern they call the “Lean Mass Hyper-Responder” (LMHR) phenotype: LDL cholesterol above 200 mg/dL, HDL cholesterol above 80 mg/dL, and triglycerides below 70 mg/dL, all appearing together during carbohydrate restriction.⁹ The relationship with body weight runs opposite to what most people expect: lower BMI predicted larger LDL increases on carbohydrate restriction, and better baseline metabolic markers (such as a low triglyceride-to-HDL ratio) predicted bigger LDL jumps.

The leading explanation is what has been termed the lipid energy model. When a relatively lean person cuts carbohydrates deeply enough to deplete liver glycogen, adipose tissue releases more free fatty acids. The liver takes these up and repackages them into VLDL particles for export. Increased VLDL production and turnover ultimately generates more LDL as part of the normal lipoprotein cascade. The same process also reduces triglyceride content in lipoproteins and transfers surface components to HDL particles, which is why HDL rises and triglycerides fall alongside the LDL spike.¹⁰ A case report further demonstrated that this LMHR phenomenon does not depend on high saturated fat intake and appears to track inversely with BMI changes rather than with specific dietary fat composition.¹¹

Whether the LMHR pattern carries the same cardiovascular risk as an equivalently high LDL from other causes remains an active question. Early data from the KETO trial suggest the answer is not straightforward, because the accompanying metabolic profile (high HDL, low triglycerides, good insulin sensitivity) looks favorable by every measure except the LDL number. For now, the practical takeaway is that if you adopt a ketogenic diet and your LDL soars while you feel great on every other metric, you are likely experiencing this phenomenon and should discuss it with a clinician who understands the nuance.

Insulin Resistance and Type 2 Diabetes

Insulin resistance rewires how the liver handles fat in ways that reliably push lipid numbers in the wrong direction. When cells stop responding normally to insulin, the liver ramps up production of triglycerides. This drives overproduction of large, triglyceride-rich VLDL1 particles, which the body then remodels into small, dense LDL particles.¹² The total LDL-cholesterol number on a standard lab report may not look dramatically elevated in someone with insulin resistance, because the change is more about particle quality than quantity: many small, dense LDL particles rather than fewer large ones. But these small particles are considered more harmful per particle because they penetrate artery walls more easily and are more susceptible to oxidation.

The cascade works through a specific enzyme called microsomal triglyceride transfer protein (MTP), which helps load triglycerides onto apolipoprotein B inside the liver to form VLDL. Insulin resistance and the resulting high insulin levels increase MTP activity, accelerating the assembly line of VLDL1 and, downstream, small dense LDL.¹³ This is why improving insulin sensitivity through weight loss, exercise, or medication often improves the full lipid profile, not just blood sugar.

Hypothyroidism

An underactive thyroid is one of the most common and most treatable secondary causes of high LDL. Thyroid hormones stimulate the catabolism, or breakdown, of LDL by upregulating LDL-receptor activity. When thyroid hormone levels fall, fewer LDL receptors appear on liver cells, and LDL clearance slows.¹⁴ The effect on LDL is independent of changes in cholesterol synthesis, absorption, or bile-acid excretion; it operates purely through reduced clearance. Even subclinical hypothyroidism, in which thyroid-stimulating hormone is mildly elevated but free thyroid hormone levels remain in the normal range, can push LDL up enough to show on a standard lipid panel. This is why guidelines recommend checking thyroid function before starting cholesterol-lowering medication: restoring thyroid hormone to normal may be all that is needed.

Kidney and Liver Disease

Nephrotic syndrome, a condition in which the kidneys leak large amounts of protein into the urine, causes some of the most pronounced lipid abnormalities in medicine. The liver compensates for protein loss by ramping up production across the board, including a dramatic increase in lipoprotein output. In animal models, the liver’s synthesis of VLDL, LDL, and HDL all increased roughly five- to sixfold during nephrotic syndrome.¹⁵ The overproduction is compounded by decreased clearance: the expression and activity of key enzymes involved in lipoprotein breakdown, including LDL receptors, lipoprotein lipase, and hepatic lipase, are all altered.¹⁶

Liver disease raises LDL through a completely different and often overlooked mechanism. In cholestatic conditions, where bile flow from the liver is blocked or impaired, an abnormal lipoprotein called lipoprotein X (LpX) accumulates in the blood. LpX is structurally different from normal LDL but migrates in the same density range, so standard lab assays count it as LDL cholesterol.¹⁷ This means the LDL number on the lab report can be dramatically and misleadingly elevated. LpX is considered ultra-rare, but it can appear with significant liver disease or bile duct obstruction, and recognizing it matters because treating it as ordinary high LDL with a statin would miss the actual problem.¹⁸

Medications That Raise LDL

Several commonly prescribed drugs can nudge LDL upward as a side effect. Corticosteroids are among the most consistent offenders. In patients with adrenal insufficiency, those taking prednisolone had significantly higher LDL cholesterol (about 3.9 mmol/L) compared to those on hydrocortisone (about 3.2 mmol/L), a gap that persisted at follow-up as well.¹⁹ The practical relevance here extends to anyone on long-term oral corticosteroids for conditions like autoimmune disease or organ transplant rejection.

Certain blood pressure medications have long had a reputation for worsening lipid profiles, but the picture is more nuanced than the reputation suggests. Thiazide diuretics like hydrochlorothiazide showed a modest short-term bump in total cholesterol (a few milligrams per deciliter) in a large controlled trial, but only in patients whose blood pressure failed to respond to the drug. Among those whose blood pressure improved, lipid profiles stayed stable. After a full year of treatment, there were no significant adverse changes in LDL across any of the treatment groups, including beta-blockers like atenolol.²⁰ Other drug classes sometimes flagged include certain immunosuppressants (cyclosporine, sirolimus), retinoids used for skin conditions, and protease inhibitors used in HIV treatment. If your LDL rose after starting a new medication, it is worth raising with your prescriber rather than assuming the number is permanent.

Aging and Hormonal Shifts

LDL cholesterol tends to climb with age. In humans, aging triggers increased plasma concentrations of triglycerides, LDL, and total cholesterol, while the capacity of HDL to remove cholesterol from cells declines.²¹ Part of this reflects a gradual decline in LDL-receptor expression on liver cells, which slows clearance. Part of it reflects hormonal changes. Estrogen promotes LDL-receptor activity, so the loss of estrogen at menopause reliably raises LDL in women, sometimes steeply enough that a woman who has had perfect lipid panels her whole life suddenly sees elevated LDL in her 50s. Testosterone changes in men have smaller, less consistent effects on LDL. Weight gain, reduced physical activity, and dietary shifts that tend to accompany aging compound the biological changes.

Sleep Disruption and the Bile Acid Connection

Sleep is an underappreciated player in cholesterol metabolism. In animal research, sleep disturbance increased serum cholesterol through a specific pathway: it altered the expression of a nuclear receptor called NR1D1, which in turn inhibited CYP7A1, a critical enzyme in the conversion of cholesterol into bile acids. With less cholesterol being converted and excreted as bile, levels backed up in the blood and liver.²² The mechanism is plausible and fits with what we know about circadian regulation of liver enzymes. However, a pooled analysis of two randomized trials in healthy humans found that prolonged insufficient sleep did not increase LDL or total cholesterol; in premenopausal women, LDL actually fell slightly during sleep restriction.²³ The discrepancy likely reflects differences between acute experimental sleep disruption in animals and the more complex human response, where compensatory mechanisms, dietary changes, and stress hormones all interact. The honest summary is that chronic poor sleep probably does not help your cholesterol, but it is not the straightforward cause that some headlines suggest.

The bile acid pathway that sleep disruption interferes with also connects to a broader story about gut health. Bile acids are made in the liver from cholesterol, secreted into the gut, and then largely reabsorbed. A nuclear receptor in the liver called FXR governs this cycle. When FXR signaling is disrupted, CYP7A1 (the same enzyme suppressed by sleep disturbance) gets overactivated, bile acid composition shifts, and the feedback loop between gut and liver breaks down. Recent research has shown that hepatic FXR loss remodels the gut’s bile acid pool, damages gut barrier integrity, and triggers microbial dysbiosis, all of which worsen dyslipidemia.²⁴ This gut-liver axis is an emerging frontier in lipid research: the composition of your gut bacteria may influence how efficiently your body recycles cholesterol into bile, and disruption of that cycle can contribute to elevated LDL in ways that standard risk calculators do not account for.

When the Lab Number Itself Is Misleading

Most routine lipid panels do not measure LDL cholesterol directly. Instead, they calculate it using a formula that subtracts HDL cholesterol and an estimate of VLDL from total cholesterol. This formula, developed decades ago, works well when triglycerides are in a normal range. But when triglycerides are elevated, the formula increasingly underestimates true LDL. A large database study found that the discrepancy between the calculated and directly measured LDL values widened as triglycerides rose: at moderately elevated triglycerides the median gap was about 6 mg/dL, and at high triglycerides the calculated value could underestimate true LDL substantially.²⁵ This matters in two directions: a person with high triglycerides may have a falsely reassuring LDL number on a standard panel, while someone being treated for high LDL may appear to be responding to therapy when their true LDL has not dropped as much as it seems. If your triglycerides are above about 200 mg/dL, a directly measured LDL or an advanced lipoprotein test gives a more accurate picture.

The LpX problem described earlier is an even more dramatic version of this issue. Because lipoprotein X sits in the same density range as LDL, both calculated and directly measured LDL assays will count it as LDL cholesterol. The only way to spot LpX is through specialized testing like lipoprotein electrophoresis or nuclear magnetic resonance spectroscopy. Clinicians who see an unexplained, abrupt spike in LDL in a patient with liver disease should consider this possibility before reflexively prescribing a statin.

When Multiple Causes Stack

In practice, elevated LDL rarely comes from one source. A person might carry a modest polygenic burden, eat a diet high in saturated fat, have mildly low thyroid function, and sleep poorly. Each of those individually might raise LDL by a manageable amount, but together they can push it well above guideline thresholds. This stacking effect is part of why two people eating the same diet can have wildly different LDL levels, and why the same person’s LDL can shift by 30 or 40 mg/dL across different periods of life without any obvious dietary change. Hormonal transitions (menopause, andropause), weight fluctuations, new medications, and changes in sleep or stress patterns all feed into the same clearance and production machinery in the liver.

Identifying which contributors matter most for a given individual is the real clinical challenge. If your LDL is elevated, a thorough workup might include checking thyroid function, fasting glucose and insulin, kidney protein excretion, and liver enzymes before attributing everything to diet or genetics. When LDL is extremely high without an obvious secondary cause, genetic testing for FH can guide treatment decisions, since people with FH often need medication from an early age and may not respond sufficiently to diet alone. For the majority of people with moderately elevated LDL, the answer is usually a combination of inherited susceptibility and modifiable factors, and addressing the modifiable ones (dietary fat quality, physical activity, weight management, sleep) typically brings the number down to a degree that reflects how many of those levers are being pulled at once.